SCHEMBL7060435

SCHEMBL7060435

COc1ccc(-c2cc3ncccc3[nH]2)c(C(=O)S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 3/20 0.46
KDM5A P29375 2/20 0.46
KDM5B Q9UGL1 2/20 0.46
ITK Q08881 2/20 0.39
DRD3 P35462 1/20 0.39
RAB9A P51151 3/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.39
KMT2A Q03164 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
BCAT1 P54687 1/20 0.39
PDE10A Q9Y233 3/20 0.39
HSD11B1 P28845 1/20 0.39
PDE2A O00408 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ATM Q13315 1/20 0.38
LMNA P02545 1/20 0.37
MET P08581 1/20 0.37
HTR6 P50406 2/20 0.37
PLK4 O00444 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7061816 0.85 KDM4E (0.50) RAB9AMEN1NPC1KMT2ABCAT1
SCHEMBL7608317 0.74 PDE2A (0.44) KDM4CKDM5AKDM5BITKDRD3
SCHEMBL7066132 0.73 PDGFRB (0.54) ALDH1A1CHEK1AURKAPDGFRBKDR
SCHEMBL27658712 0.69 CSNK1A1 (0.47) KDM4CKDM5AKDM5BRAB9ACCNB2
SCHEMBL5716844 0.68 KDR (0.49) RAB9AMEN1NPC1KMT2ABCAT1
SCHEMBL5716893 0.65 KDM4E (0.47) ITKRAB9AMEN1NPC1KMT2A
SCHEMBL5207592 0.65 KDR (0.69) ITKCHEK1PDGFRBKDRCDK5
SCHEMBL25175575 0.65 KDM4E (0.62) ITKRAB9AMEN1NPC1KMT2A
SCHEMBL7060431 0.64 KDM4C (0.47) KDM4CKDM5AKDM5BMEN1KMT2A
SCHEMBL6489332 0.63 CCNB2 (0.61) KDM4CKDM5AKDM5BRAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030158216-A1 2-acyl indole derivatives and their use as antitumor agents BAXTER ONCOLOGY GMBH 2003-08-21 US disclosed
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents BECKERS THOMAS (DE) 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158216-A1 2-acyl indole derivatives and their use as antitumor agents IDO1, IDO2, INMT KDM4C 3331/4885KDM5A 1677/4885KDM5B 2242/4885
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents IDO1, IDO2, INMT KDM4C 3331/4885KDM5A 1677/4885KDM5B 2242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.